In Genome Biology this week: epigenetic differences in CML cells, predicting aggressive prostate cancer, and more.
An international team of researchers examined differential gene expression in blood samples from patients infected during the West African outbreak.
In Cell this week: Ebola virus improved ability to infect humans during recent outbreak, and more.
The Ebola virus may have mutated to better infect humans during the 2014 outbreak, the New York Times reports.
US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
The assay is the twelfth to be granted Emergency Use Authorization by the US Food and Drug Administration for Ebola testing.
A temporary sequencing facility in Sierra Leone that was used to sequence Ebola has been moved to a new infectious disease laboratory at the University of Makeni.
Ebola virus genomes from a post-epidemic flare-up last June showed relatively low genetic divergence compared with related strains from the broader outbreak.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.